< Back to previous page
Researcher
Olivier De Wever
- Keywords:Medicine
Affiliations
- Clinical sciences (Department)
Member
From1 Oct 2017 → Today - Clinical sciences (Department)
Member
From1 Oct 2017 → 20 Oct 2022
Publications
1 - 5 of 5
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma(2023)
Authors: Emiel A De Jaeghere, Sandra Tuyaerts, An Van Nuffel, Ann Belmans, Kris Bogaerts, Regina E. M. Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stéphanie Henry, xuan bich trinh, et al.
Pages: 475-491 - Systemically circulating bacterial extracellular vesicles(2022)
Authors: An Hendrix, Olivier De Wever
Pages: 213-216 - Heterogeneity of CAFfeinated Tumors(2022)
Authors: Olivier De Wever
Pages: 537-538 - Targeting USP13 mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in Non-Small Cell Lung Cancer(2021)
Authors: Philippe Giron, Carolien Eggermont, Maxim Noeparast, Hugo Vandenplas, Erik Teugels, Ramses G Forsyth, Olivier De Wever, Pedro Aza-Blanc, Gustavo J Gutierrez, Jacques De Greve
Pages: 2579-2593 - Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer(2018)
Authors: Alfiah Noor, Ijeoma Umelo, Peter Kronenberger, Philippe Giron, Elly De Vlieghere, Olivier De Wever, Erik Teugels, Jacques De Grève
Pages: 28731-28744